Green-top Guideline No. 38, published in September 2020, provides comprehensive guidance on the management of Gestational Trophoblastic Disease (GTD). The guideline covers the presentation, diagnosis, management, treatment, and follow-up of GTD and GTN, as well as advice on future pregnancy outcomes and contraception. It emphasizes the importance of histological examination for the definitive diagnosis of molar pregnancies and recommends suction curettage for removal. The guideline also outlines the optimal follow-up and treatment for GTN, highlighting the excellent long-term outcome for women treated for GTN. Individualized support for women and their families is emphasized throughout the GTD journey.